>>Well, hi everybody, John Walls here, continuing our coverage on the cube of splunk.com 21. And then we talked a lot about data these days of companies and enterprise all the way down to small business and the importance of day to day to security data protection. But the public sector also has those very same concerns and some unique worries as well. And with me to talk about the public sector and its data transformation, and of course what's going on in that space is Jeremy Reesey, who was the group vice president of the public sector at Splunk. Jeremy. Good to see you today. Thanks for joining us. Thank you. >>Thanks for making time for me, John. You bet. >>Glad to have you. Well, let's, let's just, if first off, let's just paint the picture for those watching who are kind of focused on the private sector a little bit, just share with some general thoughts about the public sector and what's going on in terms of its digital transformation and what kind of concerns or, um, I guess, challenges you think there are broadly speaking first in the public sector around. >>Thanks, John. There's quite a bit of transformation going on right now in our government. And just like in industry, we've seen the pandemic as a catalyst for a lot of that transformation. Uh, you may have seen that Splunk recently released a report on the state of data innovation. And what we found is that, um, a lot of good things are happening, but the government still has a lot of work to do. And so there were pockets of excellence that we saw in the last 18 months where agencies really responded to things like the requirement for vaccinations and the requirement for monitoring, uh, health status in general. Uh, and we saw tremendous, um, speed in rolling out things like tele-health across, uh, the veterans affairs administration. But, uh, we also saw in our report that there were many agencies that haven't yet been able to modernize in the way that they want. And one of the inhibitors to that, frankly, John is their ability to adopt software as a service. And so we've seen a lot of things happening in the last year that, um, moved agency customers towards software as a service, but there's work yet. >>So, and why is that? So when you're talking about SAS, is it, is it, um, bureaucratic, uh, red tape as a regulatory issues? Or is it just about, uh, this is a large, huge institution that makes independent decisions, you know, HHS might make decisions separate from state separate from deity, uh, and then it's fragmented. I mean, what are those challenges? >>Sure. Well, I think there are two sides of a John. I think that our government is inherently designed to move cautiously and to move in such a way that we don't make mistakes. Uh, you use the word re bureaucratic. I'm not a huge fan of that word, but I understand the sentiment. Uh, I think that there are layers to any decision that any part of the government makes and certainly that support of, um, inhibiting speed. But I think the other part of it is our acquisition rules and regulations. And I think we've seen a number of positive changes made, uh, not only in the last administration, but even in this current administration that are helping our government agencies to take advantage of software as a service. Um, but there's still work to do there as well. Uh, we've seen the rise of things like, uh, other transactional authorities, OTAs. Uh, we've seen the establishment of an agile procurement office inside the general services administration, GSA, uh, but uh, other parts have heritage systems, systems that are working really well. And you don't want to change something that's not broken just for the sake of changing it. You want to change it in such a way, uh, that you really do transform and deliver new capabilities. >>Yeah. And I guess, um, you know, it's a matter of obviously of developing an expertise and, and maybe confidence too, right? Because this is, this is a new world, a new tech world, if you will here in the 21st century. And, um, and maybe I misused the word bureaucratic. Um, and I know you said you don't like it, but, but there's a certain kind of institutional energy or whatever you want to call it that kind of prohibits fast changes and, and is cautious and is conservative because, I mean, these are big dollar decisions and they're important decisions to based on security. So, I mean, how do you wrap your arms around that from a Splunk perspective to deal with the government, you know, at large, uh, when they have those kinds of, um, uh, I guess considerations >>Certainly, well, the beauty of where we find ourselves today is that data is incredibly powerful and there's more data available to our agency customers or to any company than ever before. So Splunk is inherently a data platform. We allow our customers be the agency customers, or be the industry customers to ask questions of data that they collect from any source, be it a structured data or unstructured data using Splunk, a customer can say, what's happening. Why is it happening? Where is it happening? And that's incredibly powerful. And I think, um, in this current age where, uh, the pandemic is forcing us to rethink how we deliver services and citizen services specifically, uh, having a data platform is incredibly powerful because the way that we're answering questions today is different than the way we answered questions last year. And it may be very different the way we have to ask questions a year from now. Uh, and that's really what Splunk's is delivering to our customers is that flexibility to be able to ask any question of any data set, uh, and to ask those questions in the context of today, not just the context that they knew yesterday. >>Yeah. W w and you mentioned the pandemic, what has that impact then? Um, obviously the need of, uh, I think about, you know, vaccination of disease, monitoring of outbreak monitoring, uh, emergency care, ICU units, all these things, um, critically important to the government's role right now, um, and continue to be, so what kind of impact has the, the pandemic had in terms of their modernization plans? Um, I'm guessing some of these had to be put on hold, right? Because you've, you've got, uh, you've got an emergency and so you can't conduct business as usual. >>Sure. So it's caused a shift in priorities as you know, John, and then it's also caused us to rethink what has to be done in person and what can be done remotely. And when we think about what can be done remotely, we're seeing a proliferation of devices. Um, we're seeing a proliferation of, uh, the, the level of network access, uh, that is enabled and supported. And with that, we see new security concerns, right? We are seeing, uh, uh, really, uh, an intriguing rise of thought around authentication and making sure that the right person is coming in from the right device, uh, using the right applications at the right time, that is incredibly challenging for our agency customers. Uh, and they have to think about what's happening in, in ways that they didn't have to last year. >>Let's talk about certification a little bit, and I know you announced a FedRAMP a couple of years ago, and now you've come out with a new iteration, if you will. Um, I hear about that. So walk me through that a little bit in our audience as well. And then just talk about the value of certification. Why does that really matter? What's the importance of that? >>Thanks, John. We did recently announced that we've received a provisional authority to operate, uh, in aisle five impact level five. And that's incredibly exciting. I've, I've never worked for a software company that had FedRAMP certification previously. And I think it demonstrates Splunk's commitment to this market, the public sector market. Uh, we are absolutely, um, committed to delivering our software in any environment at any level of classification that our customers need, and that allows them to rest assured that they can decide anything they want to about their data without worrying about the sanctity of that data itself, or the platform that they're using to process that data. That's incredibly exciting. I hope, >>Yeah. You mentioned, uh, the current administration just a little bit ago, you know, the Biden administration, um, no executive orders, you know, focusing in on, on, um, use of, of, uh, or I guess taking appropriate measures, right. To protect your data cyber from a cyber security perspective. Um, what exactly has that done to change the approach the government is taking now, uh, to protecting data and then how have you adapted to that executive order to provide the right services for governments looking to, to make sure they meet those standards and that criteria? >>Well, it's an exciting time as you, as you point out on May 12th, president Biden's son and executive order on improving the nation's cybersecurity. So, uh, from the highest levels, we're seeing the government sort of set a baseline for what makes sense. And they went further in a memo just released on August 27th, uh, by releasing what they call an enterprise logging maturity model. And it has four levels. And it, it indicates what sorts of data agencies should be storing from, and in their systems and for how long they should be storing it. And that's incredibly exciting because a lot of agencies are using Splunk, uh, to make sense of that data. And so this gives them sort of a baseline for what data do they need to collect? How long do they need to keep it collected for what questions do they need to ask of it? And as a result, um, we're making some offers to our customers about how they use Splunk, uh, how they take advantage of our cloud-based storage within our product, um, how they take advantage of our services in mapping their data strategy to this enterprise logging maturity model. And it represents a great opportunity to sort of take a step forward in cybersecurity for these agency customers. >>Yeah. I'm kind of curious here. I mean, I, I came from the wireless space and we had an active dialogue with the government in terms of, uh, communications, emergency communications, um, and, um, and also in, in services, the rural areas, that kind of thing. But sometimes that collaboration didn't go as smoothly as we would've liked, frankly. And, and so maybe lessons have been learned from that in terms of how the private sector melds with the public sector and works with the policy makers, you know, in that respect, what, how would you characterize just overall the relationship, you know, the public private sector relationship in terms of, you know, the sharing of resources and of information and collaboration? >>Well at the federal government level, uh, there's always been pretty incredible collaboration between industry and government, but I think, um, we at Splunk have been engaged through organizations like the Alliance for digital innovation, uh, the us chamber of commerce, um, act by act the American council for technology and the industry advisory council. And we're seeing a rise actually in university partnerships as well, particularly at the state level where, uh, let's say local governments are saying, Hey, we don't have the capacity to do some of these things that we now know we need to do. And we know that, uh, some of those things could be done in collaboration with our university partners and with our state partners. Um, and that's exciting. I think that it is an era where everyone realizes there are new threats. Uh, there are threats that are, um, hard to handle in a silo and that the more we collaborate, whether it's government industry collaboration, or whether it's cross government collaboration, or whether it's cross industry collaboration, the better, and the more effectively, uh, we'll solve some of these problems that face us as a nation. >>What do you make a great point too? Because, uh, it is about pulling resources at some point, and everybody pulling together, uh, in order to combat what has become a certainly vaccine, uh, challenge to say the least Jeremy, thanks for the time. Uh, I appreciate it. And, uh, wish you all the success down the road. >>Thanks for having me, John, you >>Bet Jeremy Risa joining us, talking about the public sector and sparks just exemplary work in that respect. You're watching the cube. Our coverage continues here of.com for 21.

>>Hi, everyone. Good afternoon. Thank you for joining this session. I feel honored to be invited to speak here today. And I also appreciate entity research Summit members for organ organizing and giving this great opportunity. Please let me give a quick introduction. First, I'm a Takashi from Marvin American population, and I'm leading technology scouting and global ation with digital health companies such as Business Alliance and Strategically Investment in North America. And since we started to focus on this space in 2016 our team is growing. And in order to bring more new technologies and services to Japan market Thesis year, we founded the new service theories for digital health business, especially, uh, in medical diagnosis space in Japan. And today I would like to talk how health care has been transformed for my micro perspective, and I hope you enjoy reasoning it. So what's happened since the US identify the first case in the middle of January, As everyone knows, unfortunately, is the damaged by this pandemic was unequal amongst the people in us. It had more determined tal impact on those who are socially and economically vulnerable because of the long, long lasting structural program off the U. S. Society and the Light Charity about daily case rating elevator country shows. Even in the community, the infection rate off the low income were 4.5 times higher than, uh, those of the high income and due to czar straight off the Corvette, about 14 million people are unemployed. The unique point off the U. S. Is that more than 60% of insurance is tied with employment, so losing a job can mean losing access to health care. And the point point here is that the Corvette did not create healthcare disparity but, uh nearly highlighted the underlying program and necessity off affordable care for all. And when the country had a need to increase the testing capacity and geographic out, treat the pharmacies and retails joined forces with existing stakeholders more than 90% off the U. S Corporation live within five miles off a community pharmacy such as CVS and Walgreen, so they can technically provide the test to everyone in all the community. And they also have a huge workforce memory pharmacist who are eligible to perform the testing scale, and this very made their potential in community based health care. Stand out and about your health has provided on alternative way for people to access to health care. At affordable applies under the unusual setting where social distancing, which required required mhm and people have a fear of infection. So they are afraid to take a public transportacion and visit >>the doctor the same thing supplied to doctor and the chart. Here is a number of total visit cranes by service type after stay at home order was issued across the U. S. By Ali April patient physical visits to doctor's offices or clinics declined by ALAN 70%. On the other hand, that share, or telehealth, accounted for 25% of the total total. Doctor's visit in April, while many states studied to re opening face to face visit is gradually recovering. And overall Tele Health Service did not offset the crime. Physician Physical doctor's visit and telehealth John never fully replace in person care. However, Telehealth has established a new way to provide affordable care, especially to vulnerable people, and I don't explain each player's today. But as an example, the chart shows the significant growth of the tell a dog who is one of the largest badger care and tell his provider, I believe there are three factors off paradox. Success under the pandemic. First, obviously tell Doc could reach >>the job between those patients and doctors. Majority of the patients who needed to see doctors who are those who have underlying health conditions and are high risk for Kelowna, Bilis and Secondary. They showed their business model is highly scalable. In the first quarter of this year, they moved quickly to expand their physical physicians network to increase their capacity and catch up growing demand. To some extent, they also contributed to create flexible job for the doctors who suffered from Lydia's appointment and surgery. They utilized. There are legalism to maximize the efficiency for doctors and doing so, uh, they have university maintained high quality care at affordable applies Yeah, and at the same time, the government recognize the body of about your care and de regulated traditional rules to sum up she m s temporary automated to pay a wide range of tell Her services, including hospital visit and HHS temporarily waived hip hop minorities for telehealth cases and they're changed allowed provider to use communication tools such as facetime and the messenger. During their appointment on August start, the government issued a new executive order to expand tell his services beyond the pandemic. So the government is also moving to support about your health care. So it was a quick review of the health care challenges and somewhat advancement in the pandemic. But as you understand, since those challenges are not caused by the pandemic, problems will stay remain and events off this year will continuously catalyze the transformation. So how was his cherished reshaped and where will we go? The topic from here can be also applied to Japan market. Okay, I believe democratization and decentralization healthcare more important than ever. So what does A. The traditional healthcare was defined in a framework over patient and a doctor. But in the new normal, the range of beneficiaries will be expanded from patient to all citizens, including the country uninsured people. Thanks to the technology evolution, as you can download health management off for free on iTunes stores while the range of the digital health services unable everyone to participate in new health system system. And in this slide, I put three essential element to fully realize democratization and decentralization off health care, health, literacy, data sharing and security, privacy and safety in addition, taken. In addition, technology is put at the bottom as a foundation off three point first. Health stimulus is obviously important because if people don't understand how the system works, what options are available to them or what are the pros and cons of each options? They can not navigate themselves and utilize the service. It can even cause a different disparity. Issue and secondary data must be technically flee to transfer. While it keeps interoperability ease. More options are becoming available to patient. But if data cannot be shared among stakeholders, including patient hospitals in strollers and budget your providers, patient data will be fragmented and people cannot yet continue to care which they benefited under current centralized care system. And this is most challenging part. But the last one is that the security aspect more players will involving decentralized health care outside of conventional healthcare system. So obviously, both the number of healthcare channels and our frequency of data sharing will increase more. It's create ah, higher data about no beauty, and so, under the new health care framework, we needed to ensure patient privacy and safety and also re examine a Scott write lines for sharing patient data and off course. Corbett Wasa Stone Catalyst off this you saved. But what folly. Our drivers in Macro and Micro Perspective from Mark Lowe. The challenges in healthcare system have been widely recognized for decades, and now he's a big pain. The pandemic reminded us all the key values. Misha, our current pain point as I left the church shores. Those are increasing the population, health sustainability for doctors and other social system and value based care for better and more affordable care. And all the elements are co dependent on each other. The light chart explained that providing preventive care and Alan Dimension is the best way threes to meet the key values here. Similarly, the direction of community based care and about your care is in line with thes three values, and they are acting to maximize the number of beneficiaries form. A micro uh, initiative by nonconventional players is a big driver, and both CBS and Walmart are being actively engaged in healthcare healthcare businesses for many years. And CBS has the largest walking clinic called MinuteClinic, Ottawa 1100 locations, and Walmart also has 20 primary clinics. I didn't talk to them. But the most interesting things off their recent innovation, I believe, is that they are adjusted and expanded their focus, from primary care to community health Center to out less to every every customer's needs. And CBS Front to provide affordable preventive health and chronic health monitoring services at 1500 CBS Health have, which they are now setting up and along a similar line would Mark is deploying Walmart Health Center, where, utilizing tech driven solutions, they provide affordable one stop service for core healthcare. They got less, uh, insurance status. For example, more than 40% of the people in U. S visit will not every big, so liberating the huge customer base and physical locations. Both companies being reading decentralization off health care and consumer device company such as Apple and Fitbit also have helped in transform forming healthcare in two ways. First, they are growing the boundaries between traditional healthcare and consumer product after their long development airport available, getting healthcare device and secondary. They acted as the best healthcare educators to consumers and increase people's healthcare awareness because they're taking an important role in the enhancement, health, literacy and healthcare democratization. And based on the story so far, I'd like to touch to business concept which can be applied to both Japan and the US and one expected change. It will be the emergence of data integration plot home while the telehealth. While the healthcare data data volume has increased 15 times for the last seven years and will continuously increase, we have a chance to improve the health care by harnessing the data. So meaning the new system, which unify the each patient data from multiple data sources and create 360 degrees longitudinal view each individual and then it sensitized the unified data to gain additional insights seen from structure data and unable to provide personal lives care. Finally, it's aggregate each individual data and reanalyzed to provide inside for population health. This is one specific model I envision. And, uh, health care will be provided slew online or offline and at the hospital or detail store. In order to amplify the impact of health care. The law off the mediator between health care between hospital and citizen will become more important. They can be a pharmacy toe health stand out about your care providers. They provide wide range of fundamental care and medication instruction and management. They also help individuals to manage their health care data. I will not explain the details today, but Japan has similar challenges in health care, such as increasing healthcare expenditure and lack of doctors and care givers. For example, they people in Japan have physical physician visit more than 20 times a year on average, while those in the U. S. On >>the do full times it sounds a joke, but people say because the artery are healthy, say visit hospitals to see friends. So we need to utilize thes mediators to reduce cost while they maintained social place for citizens in Japan, the government has promoted, uh, usual family, pharmacist and primary doctors and views the community based medical system as a policy. There was division of dispensing fees in Japan this year to ship the core load or pharmacist to the new role as a health management service providers. And so >>I believe we will see the change in those spaces not only in the U. S, but also in Japan, and we went through so unprecedented times. But I believe it's been resulting accelerating our healthcare transformation and creating a new business innovation. And this brings me to the end of my presentation. Thank you for your attention and hope you could find something somehow useful for your business. And if you have any questions >>or comments, please for you feel free to contact me.

>>Hi, everyone. Good afternoon. Thank you for joining this session. I feel honored to be invited to speak here today. And I also appreciate entity research Summit members for organ organizing and giving this great opportunity. Please let me give a quick introduction. First, I'm a Takashi from Marvin American population, and I'm leading technology scouting and global ation with digital health companies such as Business Alliance and Strategically Investment in North America. And since we started to focus on this space in 2016 our team is growing. And in order to bring more new technologies and services to Japan market Thesis year, we founded the new service theories for digital health business, especially, uh, in medical diagnosis space in Japan. And today I would like to talk how health care has been transformed for my micro perspective, and I hope you enjoy reasoning it. So what's happened since the US identify the first case in the middle of January, As everyone knows, unfortunately, is the damaged by this pandemic was unequal amongst the people in us. It had more determined tal impact on those who are socially and economically vulnerable because of the long, long lasting structural program off the U. S. Society and the Light Charity about daily case rating elevator country shows. Even in the community, the infection rate off the low income were 4.5 times higher than, uh, those of the high income and due to czar straight off the Corvette, about 14 million people are unemployed. The unique point off the U. S. Is that more than 60% of insurance is tied with employment, so losing a job can mean losing access to health care. And the point point here is that the Corvette did not create healthcare disparity but, uh nearly highlighted the underlying program and necessity off affordable care for all. And when the country had a need to increase the testing capacity and geographic out, treat the pharmacies and retails joined forces with existing stakeholders more than 90% off the U. S Corporation live within five miles off a community pharmacy such as CVS and Walgreen, so they can technically provide the test to everyone in all the community. And they also have a huge workforce memory pharmacist who are eligible to perform the testing scale, and this very made their potential in community based health care. Stand out and about your health has provided on alternative way for people to access to health care. At affordable applies under the unusual setting where social distancing, which required required mhm and people have a fear of infection. So they are afraid to take a public transportacion and visit >>the doctor the same thing supplied to doctor and the chart. Here is a number of total visit cranes by service type after stay at home order was issued across the U. S. By Ali April patient physical visits to doctor's offices or clinics declined by ALAN 70%. On the other hand, that share, or telehealth, accounted for 25% of the total total. Doctor's >>visit in April, while many states studied to re opening face to face visit is gradually recovering. And overall Tele Health Service did not offset the crime. Physician Physical doctor's visit and telehealth John never fully replace in person care. However, Telehealth has established a new way to provide affordable care, especially to vulnerable people, and I don't explain each player's today. But as an example, the chart shows the significant growth of >>the tell a dog who is one of the largest badger care and tell his provider, I believe there are three factors off paradox. Success under the pandemic. First, obviously tell Doc could reach >>the job between those patients and doctors. Majority of the patients who needed to see doctors who are those who have underlying health conditions and are high risk for Kelowna, Bilis and Secondary. They showed their business model is highly scalable. In the first quarter of this year, they moved quickly to expand their physical physicians network to increase their capacity and catch up growing demand. To some extent, they also contributed to create flexible job for the doctors who suffered from Lydia's appointment and surgery. They utilized. There are legalism to maximize the efficiency for doctors and doing so, uh, they have university maintained high quality care at affordable applies Yeah, and at the same time, the government recognize the body of about your care and de regulated traditional rules to sum up she m s temporary automated to pay a wide range of tell Her services, including hospital visit and HHS temporarily waived hip hop minorities for telehealth cases and they're changed allowed provider to use communication tools such as facetime and the messenger. During their appointment on August start, the government issued a new executive order to expand tell his services beyond the pandemic. So the government is also moving to support about your health care. So it was a quick review of the health care challenges and somewhat advancement in the pandemic. But as you understand, since those challenges are not caused by the pandemic, problems will stay remain and events off this year will continuously catalyze the transformation. So how was his cherished reshaped and where will we go? The topic from here can be also applied to Japan market. Okay, I believe democratization and decentralization healthcare more important than ever. So what does A. The traditional healthcare was defined in a framework over patient and a doctor. But in the new normal, the range of beneficiaries will be expanded from patient to all citizens, including the country uninsured people. Thanks to the technology evolution, as you can download health management off for free on iTunes stores while the range of the digital health services unable everyone to participate in new health system system. And in this slide, I put three essential element to fully realize democratization and decentralization off health care, health, literacy, data sharing and security, privacy and safety in addition, taken. In addition, technology is put at the bottom as a foundation off three point first. Health stimulus is obviously important because if people don't understand how the system works, what options are available to them or what are the pros and cons of each options? They can not navigate themselves and utilize the service. It can even cause a different disparity. Issue and secondary data must be technically flee to transfer. While it keeps interoperability ease. More options are becoming available to patient. But if data cannot be shared among stakeholders, including patient hospitals in strollers and budget your providers, patient data will be fragmented and people cannot yet continue to care which they benefited under current centralized care system. And this is most challenging part. But the last one is that the security aspect more players will involving decentralized health care outside of conventional healthcare system. So obviously, both the number of healthcare channels and our frequency of data sharing will increase more. It's create ah, higher data about no beauty, and so, under the new health care framework, we needed to ensure patient privacy and safety and also re examine a Scott write lines for sharing patient data and off course. Corbett Wasa Stone Catalyst off this you saved. But what folly. Our drivers in Macro and Micro Perspective from Mark Lowe. The challenges in healthcare system have been widely recognized for decades, and now he's a big pain. The pandemic reminded us all the key values. Misha, our current pain point as I left the church shores. Those are increasing the population, health sustainability for doctors and other social system and value based care for better and more affordable care. And all the elements are co dependent on each other. The light chart explained that providing preventive care and Alan Dimension is the best way threes to meet the key values here. Similarly, the direction of community based care and about your care is in line with thes three values, and they are acting to maximize the number of beneficiaries form. A micro uh, initiative by nonconventional players is a big driver, and both CBS and Walmart are being actively engaged in healthcare healthcare businesses for many years. And CBS has the largest walking clinic called MinuteClinic, Ottawa 1100 locations, and Walmart also has 20 primary clinics. I didn't talk to them. But the most interesting things off their recent innovation, I believe, is that they are adjusted and expanded their focus, from primary care to community health Center to out less to every every customer's needs. And CBS Front to provide affordable preventive health and chronic health monitoring services at 1500 CBS Health have, which they are now setting up and along a similar line would Mark is deploying Walmart Health Center, where, utilizing tech driven solutions, they provide affordable one stop service for core healthcare. They got less, uh, insurance status. For example, more than 40% of the people in U. S visit will not every big, so liberating the huge customer base and physical locations. Both companies being reading decentralization off health care and consumer device company such as Apple and Fitbit also have helped in transform forming healthcare in two ways. First, they are growing the boundaries between traditional healthcare and consumer product after their long development airport available, getting healthcare device and secondary. They acted as the best healthcare educators to consumers and increase people's healthcare awareness because they're taking an important role in the enhancement, health, literacy and healthcare democratization. And based on the story so far, I'd like to touch to business concept which can be applied to both Japan and the US and one expected change. It will be the emergence of data integration plot home while the telehealth. While the healthcare data data volume has increased 15 times for the last seven years and will continuously increase, we have a chance to improve the health care by harnessing the data. So meaning the new system, which unify the each patient data from multiple data sources and create 360 degrees longitudinal view each individual and then it sensitized the unified data to gain additional insights seen from structure data and unable to provide personal lives care. Finally, it's aggregate each individual data and reanalyzed to provide inside for population health. This is one specific model I envision. And, uh, health care will be provided slew online or offline and at the hospital or detail store. In order to amplify the impact of health care. The law off the mediator between health care between hospital and citizen will become more important. They can be a pharmacy toe health stand out about your care providers. They provide wide range of fundamental care and medication instruction and management. They also help individuals to manage their health care data. I will not explain the details today, but Japan has similar challenges in health care, such as increasing healthcare expenditure and lack of doctors and care givers. For example, they people in Japan have physical physician visit more than 20 times a year on average, while those in the U. S. On the do full times it sounds a joke, but people say because the artery are healthy, say visit hospitals to see friends. So we need to utilize thes mediators to reduce cost while they maintained social place for citizens in Japan, the government has promoted, uh, usual family, pharmacist and primary doctors and views the community based medical system as a policy. There was division of dispensing fees in Japan this year to ship the core load or pharmacist to the new role as a health management service providers. And so I believe we will see the change in those spaces not only in the U. S, but also in Japan, and we went through so unprecedented times. But I believe it's been resulting accelerating our healthcare transformation and creating a new business innovation. And this brings me to the end of my presentation. Thank you for your attention and hope you could find something somehow useful for your business. And if you have any questions >>or comments, please for you feel free to contact me. Thank you.

>> Announcer: Live from Washington, D.C., it's theCUBE covering AWS Public Sector Summit 2017. Brought to you by Amazon Web Services and it's partner ecosystem. >> Welcome back, live here on theCUBE along with John Furrier, I'm John Walls. Welcome to AWS Public Sector Summit 2017. Again, live from Washington, D.C., your nation's capital, our nation's capital. With us now is our host for the week, puts on one heck of a show, I'm want to tell you, 10,000 strong here, jammed into the Washington Convention Center, Theresa Carlson from World Wide Public Sector. Nice to have you here, Theresa. >> Hi, good afternoon. >> Thanks for joining us. >> Love theCUBE and thank you for being here with us today. >> Absolutely. >> All week in fact. >> It's been great, it really has. Let's just talk about the show first off. Way back, six years ago, we could probably get everybody there jammed into our little area here, just about I think. >> Pretty much. >> Hard to do today. >> That's right. >> How do you feel about when you've seen this kind of growth not only of the show, but in your sector in general? >> I think at AWS we're humbled and excited and, on a personal level because I was sort of given the charge of go create this Public Sector business world-wide, I'm blown away, I pinch myself every time because you did hear my story. The first event, we had about 50 people in the basement of some hotel. And then, we're like, okay. And today, 10,000 people. Last year we had it at the Marriott Wardman Park and we shut down Connecticut Avenue so we knew we needed to make a change. (laughing) But it's great, this is really about our customers and partners. This is really for them. It's for them to make connections, share, and the whole theme of this is superheroes and they are our superheroes. >> One of the heroes you had on the stage today, John Edwards from the CIA, one of your poster-children if you will for great success and that kind of collaboration, said something to the effect of quote, "The best decision we ever made at the CIA "was engaging with AWS in that partnership." When you hear something like that from such a treasured partner, you got to feel pretty good. >> You just have to drop the microphone, boom, and you're sort of done. They are doing amazing work and their innovation levels are really leading, I would say, in the US Public Sector for sure and also, not just in US Public Sector but around the world. Their efforts of what they're doing and the scale and reach at which they're doing it so that's pretty cool. >> John, you've talked about the CIA moment, I'd like to hear the story, share with Theresa. >> Oh, you're going to steal my thunder here? >> No, I'm setting you up. That's what a good partner does. It's all yours. >> Well, John, we've talked multiple times already so I'll say it for the third time. The shot heard around the cloud was my definition of seminal moment, in big mega-trends there's always a moment. It was when Obama tweeted, Twitter grew, plane landing on the Hudson, there's always a seminal moment in major trends that make or break companies. For you guys, it was the CIA. Since then, it's just been a massive growth for you guys. That deal was interesting because it validated Shadow IT, validated the cloud, and it also unseated IBM, the behemoth sales organization that owned the account. In a way, a lot of things lined up. Take us through what's happened then, and since then to now. >> Well, you saw between yesterday at Werner Vogels' keynote and my keynote this morning, just the breadth and depth of the type of customers we have. Everything from the UK government, GCHQ, the Department of Justice with the IT in the UK, to the centers for Medicare for HHS, to amazing educational companies, Cal. Polytech., Australian Tax Office. That's just the breadth and depth of the type of customers we have and all of their stories were impactful, every story is impactful in their own way and across whatever sector they have. That really just tells you that the type of workloads that people are running has evolved because I remember in the early days, when you and I first talked, we talked about what are the kind of workloads and we were talking a little bit about website hosting. That's, of course, really evolved into things like machine learning, artificial intelligence, a massive scale of applications. >> Five or six years ago when we first chatted at re:Invent, it's interesting 'cause now this is the size of re:Invent what it was then so you're on a same trajectory from a show size. Again, validation to the growth in Public Sector. But I was complimenting you on our opening today, saying that you're tenacious because we've talked early days, it was a slog in the early days to get going in the cloud, you were knocking on a lot of doors, convincing people, hey, the future's going to look his way and I don't want to say they slammed the proverbial door in your face but it was more of, woah, they don't believe the cloud is ever going to happen for the government. Share some of those stories because now, looking back, obviously the world has changed. >> It has and, in fact, it's changed in many aspects of it, from policy makers, which I think would be great for you all to have on here sometime to get their perspective on cloud, but policy makers who are now thinking about, we just had a new modernization of IT mandate come out in the US Federal Government where they're going to give millions and millions of dollars toward the modernization of IT for US Government agencies which is going to be huge. That's the first time that's ever happened. To an executive order around cyber-security which is pretty much mandated to look at cloud and how you use it. You're seeing thing like that to even how grants are given where it used to be an old-school model of hardware only to now use cloud. Those ideas and aspects of how individuals are using IT but also just the procurements that are coming out. The buying vehicles that you're seeing come out of government, almost all of them have cloud now. >> John and I were talking about D.C. and the political climate. Obviously, we always talk about it on my show, comment on that. But, interesting, theCUBE, we could do damage here in D.C.. So much target-rich environment for content but more than ever, to me, is the tech scene here is really intrinsically different. For example, this is not a shiny new toy kind of trend, it is a fundamental transformation of the business model. What's interesting to me is, again, since the CIA shot heard around the cloud moment, you've seen a real shift in operating model. So the question I have for you, Theresa, if you can comment on this is: how has that changed? How has the procuring of technology changed? How has he human side of it changed? Because people want to do a good job, they're just on minicomputers and mainframes from the old days with small incremental improvement over the years in IT but now to a fundamental, agile, there's going to be more apps, more action. >> You said something really important just a moment ago, this is a different kind of group than you'll get in Silicon Valley and it is but it's very enterprise. Everybody you see here, every project they work on, we're talking DoD, the enterprise of enterprises. They have really challenging and tough problems to solve every day. How that's changed, in the old days here in government, they know how to write acquisitions for a missile or a tank or something really big in IT. What's changing is their ability to write acquisitions for agile IT, things like cloud utility based models, moving fast, flywheel approach to IT acquisitions. That's what's changing, that kind of acquisition model. Also, you're seeing the system integrator community here change. Where they were, what I call, body shops to do a lot of these projects, they're having to evolve their IT skills, they're getting much more certified in areas of AWS, at the system admin to certified solution architects at the highest level, to really roll these projects out. So training, education, the type of acquisition, and how they're doing it. >> What happened in terms of paradigm shift, mindset? Something had to happen 'cause you brought a vision to the table but somebody had to buy it. Usually, when we talk about legacy systems, it was a legacy mindset too, resistant, reluctant, cautious, all those things. >> Theresa: Well, everything gets thrown out. >> What happened? Where did it tip the other way? Where did it go? >> I think, over time, it's different parts of the government but culture is the hardest thing to, always, change. Other elements of any changes, you get there, but culture is fundamentally the hardest thing. You're seeing that. You've always heard us say, you can't fight gravity, and cloud is the new normal. That's for the whole culture. People are like, I cannot do my project anymore without the use of cloud computing. >> We also have a saying, you can't fight fashion either, and sometimes being in fashion is what the trends are going on. So I got to ask you, what is the fashion statement in cloud these days with your customers? Is it, you mentioned there, moving much down in the workload, is it multi-cloud? Is it analytics? Where's the fashionable, cool action right now? >> I think, here, right now, the cool thing that people really are talking about are artificial intelligence and machine learning, how they take advantage of that. You heard a lot about recognition yesterday, Poly and Lex, these new tools how they are so differentiating anything that they can possibly develop quickly. It's those kind of tools that really we're hearing and of course, IOT for state and local is a big deal. >> I got to ask you the hard question, I always ask Andy a hard question too, if he's watching, you're going to get this one probably at re:Invent. Amazon is a devops culture, you ship code fast and you make all these updates and it's moving very, very fast. One of the things that you guys have done well, but I still think you need some work to do in terms of critical analysis, is getting the releases out that are on public cloud into the GovCloud. You guys have shortened that down to less than a year on most things. You got the east region now rolled out so full disaster recovery but government has always been lagging behind most commercial. How are you guys shrinking that window? When do you see the day when push button commercial, GovCloud are all lockstep and pushing code to both clouds? >> We could do that today but there's a couple of big differentiators that are important for the GovCloud. That is it requires US citizenship, which as you know, we've talked about the challenges of technology and skills. That's just out there, right? At Amazon Web Services, we're a very diverse company, a group of individuals that do our coding and development, and not all of them are US citizens. So for these two clouds, you have to be a US citizen so that is an inhibitor. >> In terms of developers? In terms of building the product? >> Not building but the management aspect. Because of their design, we have multiple individuals managing multiple clouds, right? Now, with us, it's about getting that scale going, that flywheel for us. >> So now it's going to be managed in the USA versus made in the USA with everything as a service. >> Yeah, it is. For us, it's about making sure, number one, we can roll them out, but secondly, we do not want to roll services into those clouds unless they are critical. We are moving a lot faster, we rolled in a lot more services, and the other cool thing is we're starting to do some unique things for our GovCloud regions which, maybe the next time, we can talk a little bit more about those things. >> Final question for me, and let John jump in, the CIA has got this devops factory thing, I want you to talk about it because I think it points to the trend that's encouraging to me at least 'cause I'm skeptical on government, as you know. But this is a full transformation shift on how they do development. Talk about these 4000 developers that got rid of their development workstations, are now doing cloud, and the question is, who else is doing it? Is this a trend that you see happening across other agencies? >> The reason that's really important, I know you know, in the old-school model, you waited forever to provision anything, even just to do development, and you heard John talk about that. That's what he meant on this sort of workstation, this long period of time it took for them to do any kind of development. Now, what they do is they just use any move they have and they go and they provision the cloud like that. Then, they can also not just do that, they can create armies of cores or Amazon machine images so they have super-repeatable tools. Think about that. When you have these super-repeatable tools sitting in the cloud, that you can just pull down these machine images and begin to create both code and development and build off those building blocks, you move so much faster than you did in the past. So that's sort of a big trend, I would say they're definitely leading it. But other key groups are NASA, HHS, Department of Justice. Those are some of the key, big groups that we're seeing really do a lot changes in their dev. >> I got to ask you about the-- >> Oh, I have to say DHS, also DHS on customs and border patrols, they're doing the same, really innovators. >> One of the things that's happening which I'm intrigued by is the whole digital transformation in our culture, right, society. Certainly, the Federal Government wants to take care of the civil liberties of the citizens. So it's not a privacy question, it's more about where smart cities is going. We're starting to see, I call, the digital parks, if you will, where you're starting to see a digital park go into Yosemite and camping out and using pristine resources and enjoying them. There's a demand for citizens to democratize resources available to them, supercomputing or datasets, what's your philosophy on that? What is Amazon doing to facilitate and accelerate the citizen's value of technology so it can be in the hands of anyone? >> I love that question because I'll tell you, at the heart of our business is what we call citizen service, paving the way for disruptive innovation, making the world a better place. That's through citizen's services and they're access. For us, we have multiple things. Everything from our dataset program, where we fund multiple datasets that we put up on the cloud and let everybody take advantage of them, from the individual student to the researcher, for no fee. >> John F.: You pick up the cost on that? >> We do, we fund, we put those datasets in completely, we allow them to go and explore and use. The only time they would ever pay is if they go off and start creating their own systems. The most highly curated datasets up there right now are pretty much on AWS. You heard me talk about the earth, through AWS Earth that we have that shows the earth. We have weather datasets, cancer datasets, we're working with so many groups, genomic, phenotypes, genomes of rice, the rice genome that we've done. >> So this is something that you see that you're behind, >> Oh, completely. >> you're passionate about and will continue to do? >> Because you never know when that individual student or small community school is out there and they can access tools that they never could've accessed before. The training and education, that creativity of the mind, we need to open that up to everybody and we fundamentally believe that cloud is a huge opportunity for that. You heard me tell the 1000 genomes story in the past of where took that cancer dataset or that genome dataset from NIH, put it into AWS for the first time, the first week we put it up we had 3200 new researchers crowdsource on that dataset. That was the first time, that I know of, that anyone had put up a major dataset for researchers. >> And the scale, certainly, is a great resource. And smart cities is an interesting area. I want to get your thoughts on your relationship with Intel. They have 5G coming out, they have a full network transformation, you're going to have autonomous vehicles out there, you're going to have all kinds of digital. How are you guys planning on powering the cloud and what's the role that Intel will play with you guys in the relationship? >> Of course, serverless computing comes into play significantly in areas like that because you want to create efficiencies, even in the cloud, we're all about that. People have always said, oh, AWS won't do that 'cause that's disrupting themselves. We're okay with disrupting ourselves if it's the right thing. We also don't want to hog resourcing of these tools that aren't necessary. So when it comes to devices like that and IOT, you need very efficient computing and you need tools that allow that efficient computing to both scale but not over-resource things. You'll see us continue to have models like that around IOT, or lambda, or serverless computing and how we access and make sure that those resources are used appropriately. >> We're almost out of time so I'd like to shift over if we can. Really impressed with the NGO work, the non-profit work as well and your work in the education space. Just talk about the nuance, differences between working with those particular constituents in the customer base, what you've learned and the kind of work you're providing in those silos right now. >> They are amazing, they are so frugal with their resources and it makes you hungry to really want to go out and help their mission because what you will find when you go meet with a lot of these not-for-profits, they are doing some of the most amazing work that even many people have really not heard of and they're being so frugal with how they resource and drive IT. There's a program called Feed the World and I met the developer of this and it's like two people. They've fed millions of people around the world with like three developers and creating an app and doing great work. To everything from like the American Heart Association that has a mission, literally, of stopping heart disease which is our number one killer around the world. When you meet them and you see the things they're doing and how they are using cloud computing to change and forward their mission. You heard us talk about human trafficking, it's a horrible, misunderstood environment out there that more of us need to be informed on and help with but computing can be a complete differentiator for them, cloud computing. We give millions of dollars of grants away, not just give away, we help them. We help them with the technical resourcing, how they're efficient, and we work really hard to try to help forward their mission and get the word out. It's humbling and it's really nice to feel that you're not only doing things for big governments but you also can help that individual not-for-profit that has a mission that's really important to not only them but groups in the world. >> It's a different level of citizen service, right? I mean, ocean conservancy this morning, talking about that and tidal change. >> What's the biggest thing that, in your mind, personal question, obviously you've been through from the beginning to now, a lot more growth ahead of you. I'm speculating that AWS Public Sector, although you won't disclose the numbers, I'll find a number out there. It's big, you guys could run the table and take a big share, similar to what you've done with startup and now enterprise market. Do you have a pinch-me moment where you go, where are we? Where are you on that spectrum of self-awareness of what's actually happening to you and this world and your team? In Public Sector, we operate just like all of AWS and all of Amazon. We really have treated this business like a startup and I create new teams just like everybody else does. I make them frugal and small and I say go do this. I will tell you, I don't even think about it because we are just scratching the surface, we are just getting going, and today we have customers in 155 countries and I have employees in about 25 countries now. Seven years ago, that was not the case. When you're moving that fast, you know that you're just getting going and that you have so much more that you can do to help your customers and create a partner ecosystem. It's a mission for us, it really is a mission and my team and myself are really excited, out there every day working to support our customers, to really grow and get them moving faster. We sort of keep pushing them to go faster. We have a long way to go and maybe ask me five years from now, we'll see. >> How about next year? We'll come back, we'll ask you again next year. >> Yeah, maybe I'll know more next year. >> John W.: Theresa, thank you for the time, very generous with your time. I know you have a big schedule over the course of this week so thank you for being here with us once again on theCUBE. >> Thank you. >> Many time CUBE alum, Theresa Carlson from AWS. Back with more here from the AWS Public Sector Summit 2017, Washington, D.C. right after this. (electronic music)

>> Voiceover: Live from Washington D.C., it's theCube, covering AWS Public Sector Summit 2017, brought to you by Amazon Web Services and its partner Ecosystem. >> Good morning, welcome back here on theCube, the Silicon Valley or Siliconangle TV flagship broadcast, here as we continue our coverage live from the Nation's capital, Washington D.C., the AWS Public Sector Summit 2017. I'm John Walls, we're glad to have you hear on theCube along with John Furrier, good morning. >> Morning. >> Good night? >> Great night. I had two great meetings, learned some information, got some exclusive material for a story that has to do with government stuff. >> So you were kind of working then weren't you? >> I'm always working. We're in D.C. I want to put my ear to the ground and bring all these stories back to my show, Silicon Valley Friday Show, which has been on hiatus during the month of May and June for all theCube events. >> Slacker. >> I got some great metadata as they say. (laughter) >> Good about data. >> I went home and watched the Nat's game. That was my big night. Jeff McAllister is with us now, he is the GM of the Americas for Druva and Jeff, glad to have you on theCube, we appreciate the time. >> Oh gee, thank you for the opportunity and it's a pleasure to meet you. >> Alright so you guys are all data, all the time on the Cloud right? >> That's right. >> All about data protection and security, availability. Tell us a little big more just about Druva and then we'll get into maybe your relationship with AWS but first off about you, about Druva. >> I've been fortunate to be with Druva since we really embarked on our enterprise strategy. I've been part of the team that made the investment a couple of years ago to start to pursue FedRAMP and some of the specifications for the Federal Government. And as you know, we are Cloud native. We are for the Cloud and built on the Cloud. We've been a partner with AWS for over eight years now. So we've had a very strong working relationship with them and the opportunity to come and speak here today and with you gentlemen, has really been tremendously exciting and frankly they're absolutely wonderful partners to go to market with. >> Yeah, talk about a minute about how integral that obviously is to your business to have not just a relationship, but to have the relationship that you do with AWS. >> Well, AWS obviously provides a world-class platform on which to build a service like ours. For our customers, it means tremendous levels of security, tremendous data durability, a reliability and availability of that data, but also the idea that many of our customers are very mobile. They have great geographic dispersion among their employees. Their employees are engaging in other parts of the world. So availability of that Cloud and that Cloud infrastructure, in local areas is tremendously important. And for our Federal customers, the certification for ITAR and other things that are specific to that market, having a platform like GovCloud, built specifically to their specifications, to service them, creates great leverage for us and our customers. >> John F.: I mean, eight year relationship, and that's going back. >> Yes it is. >> And they're only 10 years old and they spent their 10th birthday going on their 11th year, just AWS. So, obviously they saw some federal action right away, or public sector action right away. Nature of the Cloud, very friendly to developers back then. But still it was building blocks foundational back then. >> That's right, exactly. >> What's changed? How would you chronicalize that change other than the massive growth we've seen in the market place which we've chronicalized as well but I mean, from your perspective in the public sector, this is on a nice trajectory. >> I've been in the business now for over 30 years. Started out at Data General through Sun Microsystems and I've seen much of the industry change. The one thing that has been very impressive with the public sector, is that the interval in product innovation would come to the public sector a year or two years behind what we saw in the commercial marketplace. That time and space is absolutely shrinking down to nothing. They are pursuing the same business continuity, data transformation issues the Cloud-first strategies that our commercial customers are. And frankly, the government worker today has become more mobile. And the requirements to protect that data and secure it, are at an all-time high. And the AWS platform in combination with what we do, really provides a level of security that is hard to do on your own. >> So yesterday, we talked about a term I coined, or phrase I coined, around the seminal moments in GovCloud's history and really in the Amazon public sector. Is called "the shot heard around the Cloud", and that was the CIA deal where AWS came in and beat IBM, which had a lock-in spec and they're old-school IBM, they know how to sell. The sponsorships, they had everything locked and loaded. Who knows what they were doing, wining and dining. You know how the Federal Government is? >> Jeff: That's right. >> Things were very much picked out, everything's buttoned up and then boom, Shadow IT is happening, Amazon wins. Since then, we've seen a lot of change in how people are securing, how people are deploying. >> Jeff: Right. >> No better example than data protection because there's no wall, there's no firewall. You're in the middle of it. Talk about that dynamic about how the no walls, no perimeter in the Cloud has changed the role of data and data protection. >> Sure. So, gone are the days where we can dictate the device, how somebody wants to work, what solutions they're going to use. Cloud applications like Office 365, Box, Slack, other, have really created an environment where the IT folks, want to stimulate innovation, stimulate the work in places where people want to get done. But then provide the same level of protection and governance that they would on a non-platform solution. So, watching that evolution take place, its really driven us to really have to be mindful that we're in the performance business and with that performance we have to be respectful of the requirements from a security and protection standpoint that our customers call for. FIP certification became fundamental for us being able to service the government. That led us into the pursuit now of FedRAMP, which we're now FedRAMP ready. But all of those things provide the infrastructure to allow them to embrace these new strategies and this digital transformation, be it in my Cloud-first strategy or my mobility strategy, and be able to extend that same level of security that I would need, and provide that flexibility for my users to get their jobs done. >> Yeah and honestly, Cloud native, as you know, we love Cloud native, we've covered it. >> We do too. >> Covered it from day one. (laughs) Cloud-first is kind of like a moniker that people use. >> Sure. >> Kind of an ethos. It's more of a manifesto, it's more agile. But really Amazon has never hidden the ball in the fact what they believe the future will be and that is API economy. And from day one it's all about APIs and they believe that you should have APIs everywhere. The Cloud has no perimeter so that changes the security game. But the one thing that's emerged out of all this, is a new SaaS business model for businesses and government, and federal, and education. So everything's as a service. >> Jeff: Correct. >> That is a huge deal and this is maybe nuanced a bit, but how does public sector turn into a service model with the Cloud? 'Cause that's something that everyone's kind of going at. You have Cloud natives great, we're going to be Cloud natives, check. But really what they're getting to is, everything's as a service. >> Right. It's created a lot of flexibility in the buying process. First of all, you're bringing that elasticity of demand, right? So they are able to embrace the idea that, I only pay for the services I actually consume. So, should I have a movement in employees, should I change in structure, should my usage suddenly spike, I have the ability to adjust on the fly. That's a big part of it. But the other piece of it is that we can deliver our service at a fixed price cost for a certain period of time within that government fiscal year. So not only does it become easy to manage technologically, but from a budget stand point, it makes it a very predictable cost. I'm no longer having an explosion of data that I have to manage and go off books to try and find data to provide those IOPS and storage on sight. I can simply continue to go at the same budget level that I've already set aside. >> One dynamic that has come up while you brought this up, 'cause I think it's relevant to what we were just talking about is, lock-in. Right? I mean the word lock-in has always been vendor lock-in but really that's on one side of the coin. The other side of the coin is user lock-in. So last night, one of my secret meetings I had last night was with a senior government official and we were talking about how, they're all pissed 'cause they got Microsoft Surfaces instead of Macs. They wanted Macs. So they were just handed a bunch of Microsoft Surfaces. No offense Microsoft, I love the Surface personally, but I've got a Mac here. The point is, they didn't want it. >> Jeff: Right. >> It was forced down their throat. >> Let's just shut that for a moment here. (laughs) >> This is the old way. We made a decision, we're going with this product. So this is really the flexibility point is, very interesting, 'cause now with the Cloud, you can actually do these really agile deployments. >> Jeff: Exactly. >> And give people more choice. >> That's right. The time to value on these products, we have a very large defense contractor inside the Beltway. We were able to deploy to 23,000 users worldwide in under six weeks. But we understand that we're in the performance business and the idea that our customers could leave us at any point in time when the term is up, keeps us very conscious of the specifications that they require. And frankly, it requires us to be innovative on their behalf. Certainly taking their feedback, but really starting to anticipate their requirements, so that we continue to earn that business year over year. And frankly, if you want to talk about lock-in, SaaS provides tremendous flexibility to switch when a contractor isn't performing to spec, versus a perpetual license where I'm locked in for the duration. >> And that's a fear obviously that they're going to use their dollars wisely. I want to get you to weigh in on Druva's digital transformation in back of the customer. Obviously you guys are doing well, you're in the sweet spot, data protection is a hot area. It's one of the hottest area no one really kind of looks at, but it's really hot with the Cloud. What impact are you having with customers and how are you rolling out your value proposition to the public sector? What are the key highlights? I mean, how do they work with you? Is it FedRAMP? Is it GovCloud? Just take us through your value proposition with respect to the- >> Our value proposition, I think is fairly unique. So first, we run on the most wildly accepted Cloud platform by the public sector, AWS GovCloud. Without question the market leader there. We bring all of our experience from the commercial marketplace into that same experience on GovCloud. With the added certifications of FIPS, certification 140-2 moderate. Our FedRAMP in process. We're also HIPPA certified so that we have the ability to address HHS and FDA as some of our customers. 'Cause they also process a lot of personal information that is unique to that particular agency. But at the end of the day, the piece that really is most interesting to our public sector customers is, one, this is a very easy service to bring to the Cloud at lower cost and frankly higher value. The plethora of features and the security, the ease of management that we bring, relieving them of having to manage hundreds of terrabytes of data and apps on behalf of this service, is tremendously beneficial. The predictability of the cost year over year, makes it very very easy to manage. But I think the biggest thing that people have come to embrace is that the innovation that takes place in the Cloud comes to market so much faster in the Cloud. Just think of the QA cycles and how they've been reduced 'cause we're QAing for one platform. Being able to consistently, quarter in, quarter out, deliver that additional feature set and additional value, at no additional cost to our customers, is really what they've really gelled around. >> How do you guys handle the certification processes that are going? I'm sure there'll be more. I mean, they're coming. With all the free-flowing data, I'm sure there's going to be a lot of regulations and policies and governance issues. But you've got to move fast. How do you guys move fast to certify? Is there a secret sauce? Is there a secret playbook? How do you guys stay on top of it? 'Cause automations, machine learning, what's the secret sauce? >> You know, I think it's interesting, part of the uniqueness that is Druva I think is, our ability to anticipate market demand. I think we have a very experienced team of individuals. Look at the choice to go to AWS eight years ago. It was unthinkable at that time, but its turned out to be a visionary sort of choice. We identified that FedRAMP and FIPs certification, three or four years ago, was an absolute mandate to play in this marketplace. So we went there way ahead of our success in the market but we saw a very unique opportunity to go there. So I think it's just a tremendously creative group of people. It's a very dynamic marketplace. And it's one that requires a little bravery and a little bit of thinking in advance of the marketplace. I don't know that we have any magic sauce, but so far it's worked pretty well. I think it's worked out alright. >> I always ask just to see. >> Although that's a good question. >> To that point though, eight years ago when you went, it was a leap right? >> It was. >> Big leap. And now here you are 2017, things are rolling along. I imagine your sale or your pitch has taken on a different tone because you have so much proof in the pudding now, right? >> Oh, it does. A long time ago it was strictly backup. We've now moved into governance, e-discovery, the idea of user behavior analysis so I can find anomalies that may occur so that I can avoid Cryptolocker or other sorts of viruses or things that may be able to affect the operation of my customers. All of those things have come into play that weren't there four years ago. So it's really been an advancement of the added services beyond what we just did in backup, that have really kind of driven the business and differentiated us from the market. But it's still kind of fundamentally that idea that I'm going to protect your data, make it available to you and separate now from your device and really help you manage your data wherever you're doing your work. >> I know we're running tight on time, I do want to get one more question in from your perspective because again, present and creation is really a benefit to Druva, congratulations on that. You get to ride the wave and now the wave is bigger and more sets coming in. That's to use the surfing analogy. But talk about the perspective from your personal standpoint, just the changes going on in this marketplace right now. Teresa Carlson, when we were commenting on our opening, how tenacious she's been. She's knocked on a lot of doors. Eight years ago, what the hell's cloud? No one even knew what it was right? And then the shot heard around the Cloud with the CIA deal and just more and more and more in them, this is just a great business opportunity for Amazon Web Services, not just the enterprise, which they're doing well in now. >> Right. >> They own the startup market. This could be, it could have a 90% market share of public sector. >> That's right, that's right. >> John F.: Talk about the change. What's going on? Is it the perfect storm? Is it like right now, what's the progress. >> Well you know, it seems like its a perfect storm but for somebody who's been banging at it for the last four or five years, it seems to be a little bit more evolutionary. But it's interesting, when I started at Druva, if I looked across our opportunities across the Americas. It was fairly evenly split between the idea that I'm going to do this on premise or I'm going to do it in the Cloud. Today, if I look across all o6f North America and all the commercial entities and public sector entities that we're dealing with, we're probably engaged in well over 500 opportunities at any one time, literally less than two, quarter over quarter, is now on premise. People have come to embrace the idea that this is a place where I can conduct business safely and securely. And frankly, for us, you look at that digital transformation or business transformation, we become two really compelling services to start and experiment with moving to the Cloud. So very often, we are the tip of that spear. Lets backup our endpoint devices to the Cloud, let's get out of that business, 'cause we can do it much more effectively with Druva than we can for ourselves at less cost. >> It's almost the reverse of what on prem was. I've had many opportunities where I've bumped into IT practitioners, friends and what not in the industry. "Oh, I forgot to do the backup plan. I got the procurement going on." It's kind of an afterthought, it's been kind of an afterthought. I am oversimplifying but generally, it's not the primary. When you go outside the walls of a company, into the Cloud where there's no perimeter, it's the first conversation. >> That's right. >> So I hear what you're saying and I totally agree. This is unique, it's a complete flip around. >> Well it's amazing. So often, we're backing up server data to the cloud. So now it used to be just backing up to the Cloud. Now it's, I have the application running in the Cloud and I want to back it up and secure it into another Cloud. It's completely morphing into all sorts of interesting places. But the part that's really interesting is that we will bring to our customers disaster recovery, for example. Well that's a service, we turn it on and if you never experience the disaster, you don't pay for it. It just creates a whole new mindset of how we're going to think and how we're going to approach the infrastructure that we're now building. >> No license fee. It's just if you need it, you get whacked on it and you deserve to get whacked on it because you need the service. >> Well, they know what the cost will be. We've set it up for a nominal fee but if you're fortunate enough that you never experience the problem, why should you pay for it. So literally cutting that price in half, removing the requirement of 2XL Servers and 430 tip. >> John F.: It's a new operating model. >> That's right. And the flexibility that it creates to change to your computing requirements is just phenomenal. >> Well, phenomenal, I think would be a way to describe your ascent as well. >> Oh thank you. >> So congratulations on that front. Glad you could be with us Jeff, at the show. Continued success and we hope to see you down the road on theCube. >> John, John, it was a real pleasure. >> John W.: First time right? >> It was, it was, thank you. >> John W.: You're a tour alum now or a Cube alum. (laughs) >> John F.: Cube alumni. >> Good to have you with us. >> Jeff: Thank you, thank you so much. >> Jeff McAllister with Druva. Back with more here from AWS Public Sector Summit 2017 on theCube. You're watching live in Washington D.C..

>> Welcome to the Intel AI Lounge. Today, we're very excited to share with you the Precision Medicine panel discussion. I'll be moderating the session. My name is Kay Erin. I'm the general manager of Health and Life Sciences at Intel. And I'm excited to share with you these three panelists that we have here. First is John Madison. He is a chief information medical officer and he is part of Kaiser Permanente. We're very excited to have you here. Thank you, John. >> Thank you. >> We also have Naveen Rao. He is the VP and general manager for the Artificial Intelligence Solutions at Intel. He's also the former CEO of Nervana, which was acquired by Intel. And we also have Bob Rogers, who's the chief data scientist at our AI solutions group. So, why don't we get started with our questions. I'm going to ask each of the panelists to talk, introduce themselves, as well as talk about how they got started with AI. So why don't we start with John? >> Sure, so can you hear me okay in the back? Can you hear? Okay, cool. So, I am a recovering evolutionary biologist and a recovering physician and a recovering geek. And I implemented the health record system for the first and largest region of Kaiser Permanente. And it's pretty obvious that most of the useful data in a health record, in lies in free text. So I started up a natural language processing team to be able to mine free text about a dozen years ago. So we can do things with that that you can't otherwise get out of health information. I'll give you an example. I read an article online from the New England Journal of Medicine about four years ago that said over half of all people who have had their spleen taken out were not properly vaccinated for a common form of pneumonia, and when your spleen's missing, you must have that vaccine or you die a very sudden death with sepsis. In fact, our medical director in Northern California's father died of that exact same scenario. So, when I read the article, I went to my structured data analytics team and to my natural language processing team and said please show me everybody who has had their spleen taken out and hasn't been appropriately vaccinated and we ran through about 20 million records in about three hours with the NLP team, and it took about three weeks with a structured data analytics team. That sounds counterintuitive but it actually happened that way. And it's not a competition for time only. It's a competition for quality and sensitivity and specificity. So we were able to indentify all of our members who had their spleen taken out, who should've had a pneumococcal vaccine. We vaccinated them and there are a number of people alive today who otherwise would've died absent that capability. So people don't really commonly associate natural language processing with machine learning, but in fact, natural language processing relies heavily and is the first really, highly successful example of machine learning. So we've done dozens of similar projects, mining free text data in millions of records very efficiently, very effectively. But it really helped advance the quality of care and reduce the cost of care. It's a natural step forward to go into the world of personalized medicine with the arrival of a 100-dollar genome, which is actually what it costs today to do a full genome sequence. Microbiomics, that is the ecosystem of bacteria that are in every organ of the body actually. And we know now that there is a profound influence of what's in our gut and how we metabolize drugs, what diseases we get. You can tell in a five year old, whether or not they were born by a vaginal delivery or a C-section delivery by virtue of the bacteria in the gut five years later. So if you look at the complexity of the data that exists in the genome, in the microbiome, in the health record with free text and you look at all the other sources of data like this streaming data from my wearable monitor that I'm part of a research study on Precision Medicine out of Stanford, there is a vast amount of disparate data, not to mention all the imaging, that really can collectively produce much more useful information to advance our understanding of science, and to advance our understanding of every individual. And then we can do the mash up of a much broader range of science in health care with a much deeper sense of data from an individual and to do that with structured questions and structured data is very yesterday. The only way we're going to be able to disambiguate those data and be able to operate on those data in concert and generate real useful answers from the broad array of data types and the massive quantity of data, is to let loose machine learning on all of those data substrates. So my team is moving down that pathway and we're very excited about the future prospects for doing that. >> Yeah, great. I think that's actually some of the things I'm very excited about in the future with some of the technologies we're developing. My background, I started actually being fascinated with computation in biological forms when I was nine. Reading and watching sci-fi, I was kind of a big dork which I pretty much still am. I haven't really changed a whole lot. Just basically seeing that machines really aren't all that different from biological entities, right? We are biological machines and kind of understanding how a computer works and how we engineer those things and trying to pull together concepts that learn from biology into that has always been a fascination of mine. As an undergrad, I was in the EE, CS world. Even then, I did some research projects around that. I worked in the industry for about 10 years designing chips, microprocessors, various kinds of ASICs, and then actually went back to school, quit my job, got a Ph.D. in neuroscience, computational neuroscience, to specifically understand what's the state of the art. What do we really understand about the brain? And are there concepts that we can take and bring back? Inspiration's always been we want to... We watch birds fly around. We want to figure out how to make something that flies. We extract those principles, and then build a plane. Don't necessarily want to build a bird. And so Nervana's really was the combination of all those experiences, bringing it together. Trying to push computation in a new a direction. Now, as part of Intel, we can really add a lot of fuel to that fire. I'm super excited to be part of Intel in that the technologies that we were developing can really proliferate and be applied to health care, can be applied to Internet, can be applied to every facet of our lives. And some of the examples that John mentioned are extremely exciting right now and these are things we can do today. And the generality of these solutions are just really going to hit every part of health care. I mean from a personal viewpoint, my whole family are MDs. I'm sort of the black sheep of the family. I don't have an MD. And it's always been kind of funny to me that knowledge is concentrated in a few individuals. Like you have a rare tumor or something like that, you need the guy who knows how to read this MRI. Why? Why is it like that? Can't we encapsulate that knowledge into a computer or into an algorithm, and democratize it. And the reason we couldn't do it is we just didn't know how. And now we're really getting to a point where we know how to do that. And so I want that capability to go to everybody. It'll bring the cost of healthcare down. It'll make all of us healthier. That affects everything about our society. So that's really what's exciting about it to me. >> That's great. So, as you heard, I'm Bob Rogers. I'm chief data scientist for analytics and artificial intelligence solutions at Intel. My mission is to put powerful analytics in the hands of every decision maker and when I think about Precision Medicine, decision makers are not just doctors and surgeons and nurses, but they're also case managers and care coordinators and probably most of all, patients. So the mission is really to put powerful analytics and AI capabilities in the hands of everyone in health care. It's a very complex world and we need tools to help us navigate it. So my background, I started with a Ph.D. in physics and I was computer modeling stuff, falling into super massive black holes. And there's a lot of applications for that in the real world. No, I'm kidding. (laughter) >> John: There will be, I'm sure. Yeah, one of these days. Soon as we have time travel. Okay so, I actually, about 1991, I was working on my post doctoral research, and I heard about neural networks, these things that could compute the way the brain computes. And so, I started doing some research on that. I wrote some papers and actually, it was an interesting story. The problem that we solved that got me really excited about neural networks, which have become deep learning, my office mate would come in. He was this young guy who was about to go off to grad school. He'd come in every morning. "I hate my project." Finally, after two weeks, what's your project? What's the problem? It turns out he had to circle these little fuzzy spots on these images from a telescope. So they were looking for the interesting things in a sky survey, and he had to circle them and write down their coordinates all summer. Anyone want to volunteer to do that? No? Yeah, he was very unhappy. So we took the first two weeks of data that he created doing his work by hand, and we trained an artificial neural network to do his summer project and finished it in about eight hours of computing. (crowd laughs) And so he was like yeah, this is amazing. I'm so happy. And we wrote a paper. I was the first author of course, because I was the senior guy at age 24. And he was second author. His first paper ever. He was very, very excited. So we have to fast forward about 20 years. His name popped up on the Internet. And so it caught my attention. He had just won the Nobel Prize in physics. (laughter) So that's where artificial intelligence will get you. (laughter) So thanks Naveen. Fast forwarding, I also developed some time series forecasting capabilities that allowed me to create a hedge fund that I ran for 12 years. After that, I got into health care, which really is the center of my passion. Applying health care to figuring out how to get all the data from all those siloed sources, put it into the cloud in a secure way, and analyze it so you can actually understand those cases that John was just talking about. How do you know that that person had had a splenectomy and that they needed to get that pneumovax? You need to be able to search all the data, so we used AI, natural language processing, machine learning, to do that and then two years ago, I was lucky enough to join Intel and, in the intervening time, people like Naveen actually thawed the AI winter and we're really in a spring of amazing opportunities with AI, not just in health care but everywhere, but of course, the health care applications are incredibly life saving and empowering so, excited to be here on this stage with you guys. >> I just want to cue off of your comment about the role of physics in AI and health care. So the field of microbiomics that I referred to earlier, bacteria in our gut. There's more bacteria in our gut than there are cells in our body. There's 100 times more DNA in that bacteria than there is in the human genome. And we're now discovering a couple hundred species of bacteria a year that have never been identified under a microscope just by their DNA. So it turns out the person who really catapulted the study and the science of microbiomics forward was an astrophysicist who did his Ph.D. in Steven Hawking's lab on the collision of black holes and then subsequently, put the other team in a virtual reality, and he developed the first super computing center and so how did he get an interest in microbiomics? He has the capacity to do high performance computing and the kind of advanced analytics that are required to look at a 100 times the volume of 3.2 billion base pairs of the human genome that are represented in the bacteria in our gut, and that has unleashed the whole science of microbiomics, which is going to really turn a lot of our assumptions of health and health care upside down. >> That's great, I mean, that's really transformational. So a lot of data. So I just wanted to let the audience know that we want to make this an interactive session, so I'll be asking for questions in a little bit, but I will start off with one question so that you can think about it. So I wanted to ask you, it looks like you've been thinking a lot about AI over the years. And I wanted to understand, even though AI's just really starting in health care, what are some of the new trends or the changes that you've seen in the last few years that'll impact how AI's being used going forward? >> So I'll start off. There was a paper published by a guy by the name of Tegmark at Harvard last summer that, for the first time, explained why neural networks are efficient beyond any mathematical model we predict. And the title of the paper's fun. It's called Deep Learning Versus Cheap Learning. So there were two sort of punchlines of the paper. One is is that the reason that mathematics doesn't explain the efficiency of neural networks is because there's a higher order of mathematics called physics. And the physics of the underlying data structures determined how efficient you could mine those data using machine learning tools. Much more so than any mathematical modeling. And so the second thing that was a reel from that paper is that the substrate of the data that you're operating on and the natural physics of those data have inherent levels of complexity that determine whether or not a 12th layer of neural net will get you where you want to go really fast, because when you do the modeling, for those math geeks in the audience, a factorial. So if there's 12 layers, there's 12 factorial permutations of different ways you could sequence the learning through those data. When you have 140 layers of a neural net, it's a much, much, much bigger number of permutations and so you end up being hardware-bound. And so, what Max Tegmark basically said is you can determine whether to do deep learning or cheap learning based upon the underlying physics of the data substrates you're operating on and have a good insight into how to optimize your hardware and software approach to that problem. >> So another way to put that is that neural networks represent the world in the way the world is sort of built. >> Exactly. >> It's kind of hierarchical. It's funny because, sort of in retrospect, like oh yeah, that kind of makes sense. But when you're thinking about it mathematically, we're like well, anything... The way a neural can represent any mathematical function, therfore, it's fully general. And that's the way we used to look at it, right? So now we're saying, well actually decomposing the world into different types of features that are layered upon each other is actually a much more efficient, compact representation of the world, right? I think this is actually, precisely the point of kind of what you're getting at. What's really exciting now is that what we were doing before was sort of building these bespoke solutions for different kinds of data. NLP, natural language processing. There's a whole field, 25 plus years of people devoted to figuring out features, figuring out what structures make sense in this particular context. Those didn't carry over at all to computer vision. Didn't carry over at all to time series analysis. Now, with neural networks, we've seen it at Nervana, and now part of Intel, solving customers' problems. We apply a very similar set of techniques across all these different types of data domains and solve them. All data in the real world seems to be hierarchical. You can decompose it into this hierarchy. And it works really well. Our brains are actually general structures. As a neuroscientist, you can look at different parts of your brain and there are differences. Something that takes in visual information, versus auditory information is slightly different but they're much more similar than they are different. So there is something invariant, something very common between all of these different modalities and we're starting to learn that. And this is extremely exciting to me trying to understand the biological machine that is a computer, right? We're figurig it out, right? >> One of the really fun things that Ray Chrisfall likes to talk about is, and it falls in the genre of biomimmicry, and how we actually replicate biologic evolution in our technical solutions so if you look at, and we're beginning to understand more and more how real neural nets work in our cerebral cortex. And it's sort of a pyramid structure so that the first pass of a broad base of analytics, it gets constrained to the next pass, gets constrained to the next pass, which is how information is processed in the brain. So we're discovering increasingly that what we've been evolving towards, in term of architectures of neural nets, is approximating the architecture of the human cortex and the more we understand the human cortex, the more insight we get to how to optimize neural nets, so when you think about it, with millions of years of evolution of how the cortex is structured, it shouldn't be a surprise that the optimization protocols, if you will, in our genetic code are profoundly efficient in how they operate. So there's a real role for looking at biologic evolutionary solutions, vis a vis technical solutions, and there's a friend of mine who worked with who worked with George Church at Harvard and actually published a book on biomimmicry and they wrote the book completely in DNA so if all of you have your home DNA decoder, you can actually read the book on your DNA reader, just kidding. >> There's actually a start up I just saw in the-- >> Read-Write DNA, yeah. >> Actually it's a... He writes something. What was it? (response from crowd member) Yeah, they're basically encoding information in DNA as a storage medium. (laughter) The company, right? >> Yeah, that same friend of mine who coauthored that biomimmicry book in DNA also did the estimate of the density of information storage. So a cubic centimeter of DNA can store an hexabyte of data. I mean that's mind blowing. >> Naveen: Highly done soon. >> Yeah that's amazing. Also you hit upon a really important point there, that one of the things that's changed is... Well, there are two major things that have changed in my perception from let's say five to 10 years ago, when we were using machine learning. You could use data to train models and make predictions to understand complex phenomena. But they had limited utility and the challenge was that if I'm trying to build on these things, I had to do a lot of work up front. It was called feature engineering. I had to do a lot of work to figure out what are the key attributes of that data? What are the 10 or 20 or 100 pieces of information that I should pull out of the data to feed to the model, and then the model can turn it into a predictive machine. And so, what's really exciting about the new generation of machine learning technology, and particularly deep learning, is that it can actually learn from example data those features without you having to do any preprogramming. That's why Naveen is saying you can take the same sort of overall approach and apply it to a bunch of different problems. Because you're not having to fine tune those features. So at the end of the day, the two things that have changed to really enable this evolution is access to more data, and I'd be curious to hear from you where you're seeing data come from, what are the strategies around that. So access to data, and I'm talking millions of examples. So 10,000 examples most times isn't going to cut it. But millions of examples will do it. And then, the other piece is the computing capability to actually take millions of examples and optimize this algorithm in a single lifetime. I mean, back in '91, when I started, we literally would have thousands of examples and it would take overnight to run the thing. So now in the world of millions, and you're putting together all of these combinations, the computing has changed a lot. I know you've made some revolutionary advances in that. But I'm curious about the data. Where are you seeing interesting sources of data for analytics? >> So I do some work in the genomics space and there are more viable permutations of the human genome than there are people who have ever walked the face of the earth. And the polygenic determination of a phenotypic expression translation, what are genome does to us in our physical experience in health and disease is determined by many, many genes and the interaction of many, many genes and how they are up and down regulated. And the complexity of disambiguating which 27 genes are affecting your diabetes and how are they up and down regulated by different interventions is going to be different than his. It's going to be different than his. And we already know that there's four or five distinct genetic subtypes of type II diabetes. So physicians still think there's one disease called type II diabetes. There's actually at least four or five genetic variants that have been identified. And so, when you start thinking about disambiguating, particularly when we don't know what 95 percent of DNA does still, what actually is the underlining cause, it will require this massive capability of developing these feature vectors, sometimes intuiting it, if you will, from the data itself. And other times, taking what's known knowledge to develop some of those feature vectors, and be able to really understand the interaction of the genome and the microbiome and the phenotypic data. So the complexity is high and because the variation complexity is high, you do need these massive members. Now I'm going to make a very personal pitch here. So forgive me, but if any of you have any role in policy at all, let me tell you what's happening right now. The Genomic Information Nondiscrimination Act, so called GINA, written by a friend of mine, passed a number of years ago, says that no one can be discriminated against for health insurance based upon their genomic information. That's cool. That should allow all of you to feel comfortable donating your DNA to science right? Wrong. You are 100% unprotected from discrimination for life insurance, long term care and disability. And it's being practiced legally today and there's legislation in the House, in mark up right now to completely undermine the existing GINA legislation and say that whenever there's another applicable statute like HIPAA, that the GINA is irrelevant, that none of the fines and penalties are applicable at all. So we need a ton of data to be able to operate on. We will not be getting a ton of data to operate on until we have the kind of protection we need to tell people, you can trust us. You can give us your data, you will not be subject to discrimination. And that is not the case today. And it's being further undermined. So I want to make a plea to any of you that have any policy influence to go after that because we need this data to help the understanding of human health and disease and we're not going to get it when people look behind the curtain and see that discrimination is occurring today based upon genetic information. >> Well, I don't like the idea of being discriminated against based on my DNA. Especially given how little we actually know. There's so much complexity in how these things unfold in our own bodies, that I think anything that's being done is probably childishly immature and oversimplifying. So it's pretty rough. >> I guess the translation here is that we're all unique. It's not just a Disney movie. (laughter) We really are. And I think one of the strengths that I'm seeing, kind of going back to the original point, of these new techniques is it's going across different data types. It will actually allow us to learn more about the uniqueness of the individual. It's not going to be just from one data source. They were collecting data from many different modalities. We're collecting behavioral data from wearables. We're collecting things from scans, from blood tests, from genome, from many different sources. The ability to integrate those into a unified picture, that's the important thing that we're getting toward now. That's what I think is going to be super exciting here. Think about it, right. I can tell you to visual a coin, right? You can visualize a coin. Not only do you visualize it. You also know what it feels like. You know how heavy it is. You have a mental model of that from many different perspectives. And if I take away one of those senses, you can still identify the coin, right? If I tell you to put your hand in your pocket, and pick out a coin, you probably can do that with 100% reliability. And that's because we have this generalized capability to build a model of something in the world. And that's what we need to do for individuals is actually take all these different data sources and come up with a model for an individual and you can actually then say what drug works best on this. What treatment works best on this? It's going to get better with time. It's not going to be perfect, because this is what a doctor does, right? A doctor who's very experienced, you're a practicing physician right? Back me up here. That's what you're doing. You basically have some categories. You're taking information from the patient when you talk with them, and you're building a mental model. And you apply what you know can work on that patient, right? >> I don't have clinic hours anymore, but I do take care of many friends and family. (laughter) >> You used to, you used to. >> I practiced for many years before I became a full-time geek. >> I thought you were a recovering geek. >> I am. (laughter) I do more policy now. >> He's off the wagon. >> I just want to take a moment and see if there's anyone from the audience who would like to ask, oh. Go ahead. >> We've got a mic here, hang on one second. >> I have tons and tons of questions. (crosstalk) Yes, so first of all, the microbiome and the genome are really complex. You already hit about that. Yet most of the studies we do are small scale and we have difficulty repeating them from study to study. How are we going to reconcile all that and what are some of the technical hurdles to get to the vision that you want? >> So primarily, it's been the cost of sequencing. Up until a year ago, it's $1000, true cost. Now it's $100, true cost. And so that barrier is going to enable fairly pervasive testing. It's not a real competitive market becaue there's one sequencer that is way ahead of everybody else. So the price is not $100 yet. The cost is below $100. So as soon as there's competition to drive the cost down, and hopefully, as soon as we all have the protection we need against discrimination, as I mentioned earlier, then we will have large enough sample sizes. And so, it is our expectation that we will be able to pool data from local sources. I chair the e-health work group at the Global Alliance for Genomics and Health which is working on this very issue. And rather than pooling all the data into a single, common repository, the strategy, and we're developing our five-year plan in a month in London, but the goal is to have a federation of essentially credentialed data enclaves. That's a formal method. HHS already does that so you can get credentialed to search all the data that Medicare has on people that's been deidentified according to HIPPA. So we want to provide the same kind of service with appropriate consent, at an international scale. And there's a lot of nations that are talking very much about data nationality so that you can't export data. So this approach of a federated model to get at data from all the countries is important. The other thing is a block-chain technology is going to be very profoundly useful in this context. So David Haussler of UC Santa Cruz is right now working on a protocol using an open block-chain, public ledger, where you can put out. So for any typical cancer, you may have a half dozen, what are called sematic variance. Cancer is a genetic disease so what has mutated to cause it to behave like a cancer? And if we look at those biologically active sematic variants, publish them on a block chain that's public, so there's not enough data there to reidentify the patient. But if I'm a physician treating a woman with breast cancer, rather than say what's the protocol for treating a 50-year-old woman with this cell type of cancer, I can say show me all the people in the world who have had this cancer at the age of 50, wit these exact six sematic variants. Find the 200 people worldwide with that. Ask them for consent through a secondary mechanism to donate everything about their medical record, pool that information of the core of 200 that exactly resembles the one sitting in front of me, and find out, of the 200 ways they were treated, what got the best results. And so, that's the kind of future where a distributed, federated architecture will allow us to query and obtain a very, very relevant cohort, so we can basically be treating patients like mine, sitting right in front of me. Same thing applies for establishing research cohorts. There's some very exciting stuff at the convergence of big data analytics, machine learning, and block chaining. >> And this is an area that I'm really excited about and I think we're excited about generally at Intel. They actually have something called the Collaborative Cancer Cloud, which is this kind of federated model. We have three different academic research centers. Each of them has a very sizable and valuable collection of genomic data with phenotypic annotations. So you know, pancreatic cancer, colon cancer, et cetera, and we've actually built a secure computing architecture that can allow a person who's given the right permissions by those organizations to ask a specific question of specific data without ever sharing the data. So the idea is my data's really important to me. It's valuable. I want us to be able to do a study that gets the number from the 20 pancreatic cancer patients in my cohort, up to the 80 that we have in the whole group. But I can't do that if I'm going to just spill my data all over the world. And there are HIPAA and compliance reasons for that. There are business reasons for that. So what we've built at Intel is this platform that allows you to do different kinds of queries on this genetic data. And reach out to these different sources without sharing it. And then, the work that I'm really involved in right now and that I'm extremely excited about... This also touches on something that both of you said is it's not sufficient to just get the genome sequences. You also have to have the phenotypic data. You have to know what cancer they've had. You have to know that they've been treated with this drug and they've survived for three months or that they had this side effect. That clinical data also needs to be put together. It's owned by other organizations, right? Other hospitals. So the broader generalization of the Collaborative Cancer Cloud is something we call the data exchange. And it's a misnomer in a sense that we're not actually exchanging data. We're doing analytics on aggregated data sets without sharing it. But it really opens up a world where we can have huge populations and big enough amounts of data to actually train these models and draw the thread in. Of course, that really then hits home for the techniques that Nervana is bringing to the table, and of course-- >> Stanford's one of your academic medical centers? >> Not for that Collaborative Cancer Cloud. >> The reason I mentioned Standford is because the reason I'm wearing this FitBit is because I'm a research subject at Mike Snyder's, the chair of genetics at Stanford, IPOP, intrapersonal omics profile. So I was fully sequenced five years ago and I get four full microbiomes. My gut, my mouth, my nose, my ears. Every three months and I've done that for four years now. And about a pint of blood. And so, to your question of the density of data, so a lot of the problem with applying these techniques to health care data is that it's basically a sparse matrix and there's a lot of discontinuities in what you can find and operate on. So what Mike is doing with the IPOP study is much the same as you described. Creating a highly dense longitudinal set of data that will help us mitigate the sparse matrix problem. (low volume response from audience member) Pardon me. >> What's that? (low volume response) (laughter) >> Right, okay. >> John: Lost the school sample. That's got to be a new one I've heard now. >> Okay, well, thank you so much. That was a great question. So I'm going to repeat this and ask if there's another question. You want to go ahead? >> Hi, thanks. So I'm a journalist and I report a lot on these neural networks, a system that's beter at reading mammograms than your human radiologists. Or a system that's better at predicting which patients in the ICU will get sepsis. These sort of fascinating academic studies that I don't really see being translated very quickly into actual hospitals or clinical practice. Seems like a lot of the problems are regulatory, or liability, or human factors, but how do you get past that and really make this stuff practical? >> I think there's a few things that we can do there and I think the proof points of the technology are really important to start with in this specific space. In other places, sometimes, you can start with other things. But here, there's a real confidence problem when it comes to health care, and for good reason. We have doctors trained for many, many years. School and then residencies and other kinds of training. Because we are really, really conservative with health care. So we need to make sure that technology's well beyond just the paper, right? These papers are proof points. They get people interested. They even fuel entire grant cycles sometimes. And that's what we need to happen. It's just an inherent problem, its' going to take a while. To get those things to a point where it's like well, I really do trust what this is saying. And I really think it's okay to now start integrating that into our standard of care. I think that's where you're seeing it. It's frustrating for all of us, believe me. I mean, like I said, I think personally one of the biggest things, I want to have an impact. Like when I go to my grave, is that we used machine learning to improve health care. We really do feel that way. But it's just not something we can do very quickly and as a business person, I don't actually look at those use cases right away because I know the cycle is just going to be longer. >> So to your point, the FDA, for about four years now, has understood that the process that has been given to them by their board of directors, otherwise known as Congress, is broken. And so they've been very actively seeking new models of regulation and what's really forcing their hand is regulation of devices and software because, in many cases, there are black box aspects of that and there's a black box aspect to machine learning. Historically, Intel and others are making inroads into providing some sort of traceability and transparency into what happens in that black box rather than say, overall we get better results but once in a while we kill somebody. Right? So there is progress being made on that front. And there's a concept that I like to use. Everyone knows Ray Kurzweil's book The Singularity Is Near? Well, I like to think that diadarity is near. And the diadarity is where you have human transparency into what goes on in the black box and so maybe Bob, you want to speak a little bit about... You mentioned that, in a prior discussion, that there's some work going on at Intel there. >> Yeah, absolutely. So we're working with a number of groups to really build tools that allow us... In fact Naveen probably can talk in even more detail than I can, but there are tools that allow us to actually interrogate machine learning and deep learning systems to understand, not only how they respond to a wide variety of situations but also where are there biases? I mean, one of the things that's shocking is that if you look at the clinical studies that our drug safety rules are based on, 50 year old white guys are the peak of that distribution, which I don't see any problem with that, but some of you out there might not like that if you're taking a drug. So yeah, we want to understand what are the biases in the data, right? And so, there's some new technologies. There's actually some very interesting data-generative technologies. And this is something I'm also curious what Naveen has to say about, that you can generate from small sets of observed data, much broader sets of varied data that help probe and fill in your training for some of these systems that are very data dependent. So that takes us to a place where we're going to start to see deep learning systems generating data to train other deep learning systems. And they start to sort of go back and forth and you start to have some very nice ways to, at least, expose the weakness of these underlying technologies. >> And that feeds back to your question about regulatory oversight of this. And there's the fascinating, but little known origin of why very few women are in clinical studies. Thalidomide causes birth defects. So rather than say pregnant women can't be enrolled in drug trials, they said any woman who is at risk of getting pregnant cannot be enrolled. So there was actually a scientific meritorious argument back in the day when they really didn't know what was going to happen post-thalidomide. So it turns out that the adverse, unintended consequence of that decision was we don't have data on women and we know in certain drugs, like Xanax, that the metabolism is so much slower, that the typical dosing of Xanax is women should be less than half of that for men. And a lot of women have had very serious adverse effects by virtue of the fact that they weren't studied. So the point I want to illustrate with that is that regulatory cycles... So people have known for a long time that was like a bad way of doing regulations. It should be changed. It's only recently getting changed in any meaningful way. So regulatory cycles and legislative cycles are incredibly slow. The rate of exponential growth in technology is exponential. And so there's impedance mismatch between the cycle time for regulation cycle time for innovation. And what we need to do... I'm working with the FDA. I've done four workshops with them on this very issue. Is that they recognize that they need to completely revitalize their process. They're very interested in doing it. They're not resisting it. People think, oh, they're bad, the FDA, they're resisting. Trust me, there's nobody on the planet who wants to revise these review processes more than the FDA itself. And so they're looking at models and what I recommended is global cloud sourcing and the FDA could shift from a regulatory role to one of doing two things, assuring the people who do their reviews are competent, and assuring that their conflicts of interest are managed, because if you don't have a conflict of interest in this very interconnected space, you probably don't know enough to be a reviewer. So there has to be a way to manage the conflict of interest and I think those are some of the keypoints that the FDA is wrestling with because there's type one and type two errors. If you underregulate, you end up with another thalidomide and people born without fingers. If you overregulate, you prevent life saving drugs from coming to market. So striking that balance across all these different technologies is extraordinarily difficult. If it were easy, the FDA would've done it four years ago. It's very complicated. >> Jumping on that question, so all three of you are in some ways entrepreneurs, right? Within your organization or started companies. And I think it would be good to talk a little bit about the business opportunity here, where there's a huge ecosystem in health care, different segments, biotech, pharma, insurance payers, etc. Where do you see is the ripe opportunity or industry, ready to really take this on and to make AI the competitive advantage. >> Well, the last question also included why aren't you using the result of the sepsis detection? We do. There were six or seven published ways of doing it. We did our own data, looked at it, we found a way that was superior to all the published methods and we apply that today, so we are actually using that technology to change clinical outcomes. As far as where the opportunities are... So it's interesting. Because if you look at what's going to be here in three years, we're not going to be using those big data analytics models for sepsis that we are deploying today, because we're just going to be getting a tiny aliquot of blood, looking for the DNA or RNA of any potential infection and we won't have to infer that there's a bacterial infection from all these other ancillary, secondary phenomenon. We'll see if the DNA's in the blood. So things are changing so fast that the opportunities that people need to look for are what are generalizable and sustainable kind of wins that are going to lead to a revenue cycle that are justified, a venture capital world investing. So there's a lot of interesting opportunities in the space. But I think some of the biggest opportunities relate to what Bob has talked about in bringing many different disparate data sources together and really looking for things that are not comprehensible in the human brain or in traditional analytic models. >> I think we also got to look a little bit beyond direct care. We're talking about policy and how we set up standards, these kinds of things. That's one area. That's going to drive innovation forward. I completely agree with that. Direct care is one piece. How do we scale out many of the knowledge kinds of things that are embedded into one person's head and get them out to the world, democratize that. Then there's also development. The underlying technology's of medicine, right? Pharmaceuticals. The traditional way that pharmaceuticals is developed is actually kind of funny, right? A lot of it was started just by chance. Penicillin, a very famous story right? It's not that different today unfortunately, right? It's conceptually very similar. Now we've got more science behind it. We talk about domains and interactions, these kinds of things but fundamentally, the problem is what we in computer science called NP hard, it's too difficult to model. You can't solve it analytically. And this is true for all these kinds of natural sorts of problems by the way. And so there's a whole field around this, molecular dynamics and modeling these sorts of things, that are actually being driven forward by these AI techniques. Because it turns out, our brain doesn't do magic. It actually doesn't solve these problems. It approximates them very well. And experience allows you to approximate them better and better. Actually, it goes a little bit to what you were saying before. It's like simulations and forming your own networks and training off each other. There are these emerging dynamics. You can simulate steps of physics. And you come up with a system that's much too complicated to ever solve. Three pool balls on a table is one such system. It seems pretty simple. You know how to model that, but it actual turns out you can't predict where a balls going to be once you inject some energy into that table. So something that simple is already too complex. So neural network techniques actually allow us to start making those tractable. These NP hard problems. And things like molecular dynamics and actually understanding how different medications and genetics will interact with each other is something we're seeing today. And so I think there's a huge opportunity there. We've actually worked with customers in this space. And I'm seeing it. Like Rosch is acquiring a few different companies in space. They really want to drive it forward, using big data to drive drug development. It's kind of counterintuitive. I never would've thought it had I not seen it myself. >> And there's a big related challenge. Because in personalized medicine, there's smaller and smaller cohorts of people who will benefit from a drug that still takes two billion dollars on average to develop. That is unsustainable. So there's an economic imperative of overcoming the cost and the cycle time for drug development. >> I want to take a go at this question a little bit differently, thinking about not so much where are the industry segments that can benefit from AI, but what are the kinds of applications that I think are most impactful. So if this is what a skilled surgeon needs to know at a particular time to care properly for a patient, this is where most, this area here, is where most surgeons are. They are close to the maximum knowledge and ability to assimilate as they can be. So it's possible to build complex AI that can pick up on that one little thing and move them up to here. But it's not a gigantic accelerator, amplifier of their capability. But think about other actors in health care. I mentioned a couple of them earlier. Who do you think the least trained actor in health care is? >> John: Patients. >> Yes, the patients. The patients are really very poorly trained, including me. I'm abysmal at figuring out who to call and where to go. >> Naveen: You know as much the doctor right? (laughing) >> Yeah, that's right. >> My doctor friends always hate that. Know your diagnosis, right? >> Yeah, Dr. Google knows. So the opportunities that I see that are really, really exciting are when you take an AI agent, like sometimes I like to call it contextually intelligent agent, or a CIA, and apply it to a problem where a patient has a complex future ahead of them that they need help navigating. And you use the AI to help them work through. Post operative. You've got PT. You've got drugs. You've got to be looking for side effects. An agent can actually help you navigate. It's like your own personal GPS for health care. So it's giving you the inforamation that you need about you for your care. That's my definition of Precision Medicine. And it can include genomics, of course. But it's much bigger. It's that broader picture and I think that a sort of agent way of thinking about things and filling in the gaps where there's less training and more opportunity, is very exciting. >> Great start up idea right there by the way. >> Oh yes, right. We'll meet you all out back for the next start up. >> I had a conversation with the head of the American Association of Medical Specialties just a couple of days ago. And what she was saying, and I'm aware of this phenomenon, but all of the medical specialists are saying, you're killing us with these stupid board recertification trivia tests that you're giving us. So if you're a cardiologist, you have to remember something that happens in one in 10 million people, right? And they're saying that irrelevant anymore, because we've got advanced decision support coming. We have these kinds of analytics coming. Precisely what you're saying. So it's human augmentation of decision support that is coming at blazing speed towards health care. So in that context, it's much more important that you have a basic foundation, you know how to think, you know how to learn, and you know where to look. So we're going to be human-augmented learning systems much more so than in the past. And so the whole recertification process is being revised right now. (inaudible audience member speaking) Speak up, yeah. (person speaking) >> What makes it fathomable is that you can-- (audience member interjects inaudibly) >> Sure. She was saying that our brain is really complex and large and even our brains don't know how our brains work, so... are there ways to-- >> What hope do we have kind of thing? (laughter) >> It's a metaphysical question. >> It circles all the way down, exactly. It's a great quote. I mean basically, you can decompose every system. Every complicated system can be decomposed into simpler, emergent properties. You lose something perhaps with each of those, but you get enough to actually understand most of the behavior. And that's really how we understand the world. And that's what we've learned in the last few years what neural network techniques can allow us to do. And that's why our brain can understand our brain. (laughing) >> Yeah, I'd recommend reading Chris Farley's last book because he addresses that issue in there very elegantly. >> Yeah we're seeing some really interesting technologies emerging right now where neural network systems are actually connecting other neural network systems in networks. You can see some very compelling behavior because one of the things I like to distinguish AI versus traditional analytics is we used to have question-answering systems. I used to query a database and create a report to find out how many widgets I sold. Then I started using regression or machine learning to classify complex situations from this is one of these and that's one of those. And then as we've moved more recently, we've got these AI-like capabilities like being able to recognize that there's a kitty in the photograph. But if you think about it, if I were to show you a photograph that happened to have a cat in it, and I said, what's the answer, you'd look at me like, what are you talking about? I have to know the question. So where we're cresting with these connected sets of neural systems, and with AI in general, is that the systems are starting to be able to, from the context, understand what the question is. Why would I be asking about this picture? I'm a marketing guy, and I'm curious about what Legos are in the thing or what kind of cat it is. So it's being able to ask a question, and then take these question-answering systems, and actually apply them so that's this ability to understand context and ask questions that we're starting to see emerge from these more complex hierarchical neural systems. >> There's a person dying to ask a question. >> Sorry. You have hit on several different topics that all coalesce together. You mentioned personalized models. You mentioned AI agents that could help you as you're going through a transitionary period. You mentioned data sources, especially across long time periods. Who today has access to enough data to make meaningful progress on that, not just when you're dealing with an issue, but day-to-day improvement of your life and your health? >> Go ahead, great question. >> That was a great question. And I don't think we have a good answer to it. (laughter) I'm sure John does. Well, I think every large healthcare organization and various healthcare consortiums are working very hard to achieve that goal. The problem remains in creating semantic interoperatability. So I spent a lot of my career working on semantic interoperatability. And the problem is that if you don't have well-defined, or self-defined data, and if you don't have well-defined and documented metadata, and you start operating on it, it's real easy to reach false conclusions and I can give you a classic example. It's well known, with hundreds of studies looking at when you give an antibiotic before surgery and how effective it is in preventing a post-op infection. Simple question, right? So most of the literature done prosectively was done in institutions where they had small sample sizes. So if you pool that, you get a little bit more noise, but you get a more confirming answer. What was done at a very large, not my own, but a very large institution... I won't name them for obvious reasons, but they pooled lots of data from lots of different hospitals, where the data definitions and the metadata were different. Two examples. When did they indicate the antibiotic was given? Was it when it was ordered, dispensed from the pharmacy, delivered to the floor, brought to the bedside, put in the IV, or the IV starts flowing? Different hospitals used a different metric of when it started. When did surgery occur? When they were wheeled into the OR, when they were prepped and drapped, when the first incision occurred? All different. And they concluded quite dramatically that it didn't matter when you gave the pre-op antibiotic and whether or not you get a post-op infection. And everybody who was intimate with the prior studies just completely ignored and discounted that study. It was wrong. And it was wrong because of the lack of commonality and the normalization of data definitions and metadata definitions. So because of that, this problem is much more challenging than you would think. If it were so easy as to put all these data together and operate on it, normalize and operate on it, we would've done that a long time ago. It's... Semantic interoperatability remains a big problem and we have a lot of heavy lifting ahead of us. I'm working with the Global Alliance, for example, of Genomics and Health. There's like 30 different major ontologies for how you represent genetic information. And different institutions are using different ones in different ways in different versions over different periods of time. That's a mess. >> Our all those issues applicable when you're talking about a personalized data set versus a population? >> Well, so N of 1 studies and single-subject research is an emerging field of statistics. So there's some really interesting new models like step wedge analytics for doing that on small sample sizes, recruiting people asynchronously. There's single-subject research statistics. You compare yourself with yourself at a different point in time, in a different context. So there are emerging statistics to do that and as long as you use the same sensor, you won't have a problem. But people are changing their remote sensors and you're getting different data. It's measured in different ways with different sensors at different normalization and different calibration. So yes. It even persists in the N of 1 environment. >> Yeah, you have to get started with a large N that you can apply to the N of 1. I'm actually going to attack your question from a different perspective. So who has the data? The millions of examples to train a deep learning system from scratch. It's a very limited set right now. Technology such as the Collaborative Cancer Cloud and The Data Exchange are definitely impacting that and creating larger and larger sets of critical mass. And again, not withstanding the very challenging semantic interoperability questions. But there's another opportunity Kay asked about what's changed recently. One of the things that's changed in deep learning is that we now have modules that have been trained on massive data sets that are actually very smart as certain kinds of problems. So, for instance, you can go online and find deep learning systems that actually can recognize, better than humans, whether there's a cat, dog, motorcycle, house, in a photograph. >> From Intel, open source. >> Yes, from Intel, open source. So here's what happens next. Because most of that deep learning system is very expressive. That combinatorial mixture of features that Naveen was talking about, when you have all these layers, there's a lot of features there. They're actually very general to images, not just finding cats, dogs, trees. So what happens is you can do something called transfer learning, where you take a small or modest data set and actually reoptimize it for your specific problem very, very quickly. And so we're starting to see a place where you can... On one end of the spectrum, we're getting access to the computing capabilities and the data to build these incredibly expressive deep learning systems. And over here on the right, we're able to start using those deep learning systems to solve custom versions of problems. Just last weekend or two weekends ago, in 20 minutes, I was able to take one of those general systems and create one that could recognize all different kinds of flowers. Very subtle distinctions, that I would never be able to know on my own. But I happen to be able to get the data set and literally, it took 20 minutes and I have this vision system that I could now use for a specific problem. I think that's incredibly profound and I think we're going to see this spectrum of wherever you are in your ability to get data and to define problems and to put hardware in place to see really neat customizations and a proliferation of applications of this kind of technology. >> So one other trend I think, I'm very hopeful about it... So this is a hard problem clearly, right? I mean, getting data together, formatting it from many different sources, it's one of these things that's probably never going to happen perfectly. But one trend I think that is extremely hopeful to me is the fact that the cost of gathering data has precipitously dropped. Building that thing is almost free these days. I can write software and put it on 100 million cell phones in an instance. You couldn't do that five years ago even right? And so, the amount of information we can gain from a cell phone today has gone up. We have more sensors. We're bringing online more sensors. People have Apple Watches and they're sending blood data back to the phone, so once we can actually start gathering more data and do it cheaper and cheaper, it actually doesn't matter where the data is. I can write my own app. I can gather that data and I can start driving the correct inferences or useful inferences back to you. So that is a positive trend I think here and personally, I think that's how we're going to solve it, is by gathering from that many different sources cheaply. >> Hi, my name is Pete. I've very much enjoyed the conversation so far but I was hoping perhaps to bring a little bit more focus into Precision Medicine and ask two questions. Number one, how have you applied the AI technologies as you're emerging so rapidly to your natural language processing? I'm particularly interested in, if you look at things like Amazon Echo or Siri, or the other voice recognition systems that are based on AI, they've just become incredibly accurate and I'm interested in specifics about how I might use technology like that in medicine. So where would I find a medical nomenclature and perhaps some reference to a back end that works that way? And the second thing is, what specifically is Intel doing, or making available? You mentioned some open source stuff on cats and dogs and stuff but I'm the doc, so I'm looking at the medical side of that. What are you guys providing that would allow us who are kind of geeks on the software side, as well as being docs, to experiment a little bit more thoroughly with AI technology? Google has a free AI toolkit. Several other people have come out with free AI toolkits in order to accelerate that. There's special hardware now with graphics, and different processors, hitting amazing speeds. And so I was wondering, where do I go in Intel to find some of those tools and perhaps learn a bit about the fantastic work that you guys are already doing at Kaiser? >> Let me take that first part and then we'll be able to talk about the MD part. So in terms of technology, this is what's extremely exciting now about what Intel is focusing on. We're providing those pieces. So you can actually assemble and build the application. How you build that application specific for MDs and the use cases is up to you or the one who's filling out the application. But we're going to power that technology for multiple perspectives. So Intel is already the main force behind The Data Center, right? Cloud computing, all this is already Intel. We're making that extremely amenable to AI and setting the standard for AI in the future, so we can do that from a number of different mechanisms. For somebody who wants to develop an application quickly, we have hosted solutions. Intel Nervana is kind of the brand for these kinds of things. Hosted solutions will get you going very quickly. Once you get to a certain level of scale, where costs start making more sense, things can be bought on premise. We're supplying that. We're also supplying software that makes that transition essentially free. Then taking those solutions that you develop in the cloud, or develop in The Data Center, and actually deploying them on device. You want to write something on your smartphone or PC or whatever. We're actually providing those hooks as well, so we want to make it very easy for developers to take these pieces and actually build solutions out of them quickly so you probably don't even care what hardware it's running on. You're like here's my data set, this is what I want to do. Train it, make it work. Go fast. Make my developers efficient. That's all you care about, right? And that's what we're doing. We're taking it from that point at how do we best do that? We're going to provide those technologies. In the next couple of years, there's going to be a lot of new stuff coming from Intel. >> Do you want to talk about AI Academy as well? >> Yeah, that's a great segway there. In addition to this, we have an entire set of tutorials and other online resources and things we're going to be bringing into the academic world for people to get going quickly. So that's not just enabling them on our tools, but also just general concepts. What is a neural network? How does it work? How does it train? All of these things are available now and we've made a nice, digestible class format that you can actually go and play with. >> Let me give a couple of quick answers in addition to the great answers already. So you're asking why can't we use medical terminology and do what Alexa does? Well, no, you may not be aware of this, but Andrew Ian, who was the AI guy at Google, who was recruited by Google, they have a medical chat bot in China today. I don't speak Chinese. I haven't been able to use it yet. There are two similar initiatives in this country that I know of. There's probably a dozen more in stealth mode. But Lumiata and Health Cap are doing chat bots for health care today, using medical terminology. You have the compound problem of semantic normalization within language, compounded by a cross language. I've done a lot of work with an international organization called Snowmed, which translates medical terminology. So you're aware of that. We can talk offline if you want, because I'm pretty deep into the semantic space. >> Go google Intel Nervana and you'll see all the websites there. It's intel.com/ai or nervanasys.com. >> Okay, great. Well this has been fantastic. I want to, first of all, thank all the people here for coming and asking great questions. I also want to thank our fantastic panelists today. (applause) >> Thanks, everyone. >> Thank you. >> And lastly, I just want to share one bit of information. We will have more discussions on AI next Tuesday at 9:30 AM. Diane Bryant, who is our general manager of Data Centers Group will be here to do a keynote. So I hope you all get to join that. Thanks for coming. (applause) (light electronic music)